| Authors: |
Marathe PH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Reiner AS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Bossert D; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY., Sigler AM; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY., Fournier D; Histiocytosis Association, Pitman, NJ., Brewer K; Erdheim-Chester Disease Global Alliance, DeRidder, LA., Goyal G; Division of Hematology-Oncology, The University of Alabama at Birmingham, Birmingham, AL., Atkinson TM; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY., Mao JJ; Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Panageas KS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Diamond EL; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.; Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. |
